| |
1st cross-sectional evaluation |
2nd cross-sectional evaluation |
P |
| N |
87 |
87 |
- |
| Age at evaluation [years] |
mean13.1 (3.3) |
mean23.1 (3.5) |
- |
| Time from surgery [years] |
mean12.6 (3.3) |
mean22.6 (3.4) |
- |
| BMI |
mean19.3 (3.6) |
mean23.7 (4.7) |
<0.001 |
| NYHA class ≥2 |
22/85 (25.9%) |
32/87 (36.8%) |
NS |
| Cardiovascular drugs |
10/87 (11.5%) |
31/87 (36%) |
<0.001 |
| - ACE inhibitors |
4 (4.6%) |
24 (27.6%) |
<0.001 |
| - Beta-blockers |
0 (0.0%) |
3 (3.4%) |
NS |
| - Digoxin |
9 (10.3%) |
6 (6.9%) |
NS |
| - Antiarrhythmic |
4 (4.6%) |
5 (5.7%) |
NS |
| Social status |
| - Studying |
NA |
29 (33.3%) |
- |
| - Employed |
NA |
56 (64.4%) |
- |
| -Unemployed |
NA |
2 (2.3%) |
- |
| -Disability pension |
NA |
1 (1.1%) |
- |
| Participation in sports |
NA |
73 (83.9%) |
- |
|
